About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Parkinson's Disease Drugs Market Size, Demand, Report to 2031

Parkinson's Disease Drugs Market

Parkinson's Disease Drugs Market Size, Share & Trends Analysis Report By Mechanism of Action (Dopamine Agonists, Anticholinergic, MAO-B inhibitors, Amantadine, Carbidopa-levodopa, COMT Inhibitors, Other Mechanisms of Action ) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI3633DR
Study Period 2019-2031 CAGR 4.13%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 4,785.2 million
Forecast Year 2031 Forecast Year Market Size USD 7,469.08 million
Largest Market Europe Fastest Growing Market Asia Pacific
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Parkinson's Disease Drugs Market, By Mechanism of Action (2019-2031)
    1. Dopamine Agonists
    2. Anticholinergic
    3. MAO-B inhibitors
    4. Amantadine
    5. Carbidopa-levodopa
    6. COMT Inhibitors
    7. Other Mechanisms of Action 
    1. North America
      1. North America Parkinson's Disease Drugs Market, By Mechanism of Action
        1. Dopamine Agonists
          1. Anticholinergic
            1. MAO-B inhibitors
              1. Amantadine
                1. Carbidopa-levodopa
                  1. COMT Inhibitors
                    1. Other Mechanisms of Action 
                    2. U.S.
                      1. U.S. Parkinson's Disease Drugs Market, By Mechanism of Action
                        1. Dopamine Agonists
                          1. Anticholinergic
                            1. MAO-B inhibitors
                              1. Amantadine
                                1. Carbidopa-levodopa
                                  1. COMT Inhibitors
                                    1. Other Mechanisms of Action 
                                  2. Canada
                                2. Europe
                                  1. Europe Parkinson's Disease Drugs Market, By Mechanism of Action
                                    1. Dopamine Agonists
                                      1. Anticholinergic
                                        1. MAO-B inhibitors
                                          1. Amantadine
                                            1. Carbidopa-levodopa
                                              1. COMT Inhibitors
                                                1. Other Mechanisms of Action 
                                                2. U.K.
                                                  1. U.K. Parkinson's Disease Drugs Market, By Mechanism of Action
                                                    1. Dopamine Agonists
                                                      1. Anticholinergic
                                                        1. MAO-B inhibitors
                                                          1. Amantadine
                                                            1. Carbidopa-levodopa
                                                              1. COMT Inhibitors
                                                                1. Other Mechanisms of Action 
                                                              2. Germany
                                                              3. France
                                                              4. Spain
                                                              5. Italy
                                                              6. Russia
                                                              7. Nordic
                                                              8. Benelux
                                                              9. Rest of Europe
                                                            2. APAC
                                                              1. APAC Parkinson's Disease Drugs Market, By Mechanism of Action
                                                                1. Dopamine Agonists
                                                                  1. Anticholinergic
                                                                    1. MAO-B inhibitors
                                                                      1. Amantadine
                                                                        1. Carbidopa-levodopa
                                                                          1. COMT Inhibitors
                                                                            1. Other Mechanisms of Action 
                                                                            2. China
                                                                              1. China Parkinson's Disease Drugs Market, By Mechanism of Action
                                                                                1. Dopamine Agonists
                                                                                  1. Anticholinergic
                                                                                    1. MAO-B inhibitors
                                                                                      1. Amantadine
                                                                                        1. Carbidopa-levodopa
                                                                                          1. COMT Inhibitors
                                                                                            1. Other Mechanisms of Action 
                                                                                          2. Korea
                                                                                          3. Japan
                                                                                          4. India
                                                                                          5. Australia
                                                                                          6. Singapore
                                                                                          7. Taiwan
                                                                                          8. South East Asia
                                                                                          9. Rest of Asia-Pacific
                                                                                        2. Middle East and Africa
                                                                                          1. Middle East and Africa Parkinson's Disease Drugs Market, By Mechanism of Action
                                                                                            1. Dopamine Agonists
                                                                                              1. Anticholinergic
                                                                                                1. MAO-B inhibitors
                                                                                                  1. Amantadine
                                                                                                    1. Carbidopa-levodopa
                                                                                                      1. COMT Inhibitors
                                                                                                        1. Other Mechanisms of Action 
                                                                                                        2. UAE
                                                                                                          1. UAE Parkinson's Disease Drugs Market, By Mechanism of Action
                                                                                                            1. Dopamine Agonists
                                                                                                              1. Anticholinergic
                                                                                                                1. MAO-B inhibitors
                                                                                                                  1. Amantadine
                                                                                                                    1. Carbidopa-levodopa
                                                                                                                      1. COMT Inhibitors
                                                                                                                        1. Other Mechanisms of Action 
                                                                                                                      2. Turkey
                                                                                                                      3. Saudi Arabia
                                                                                                                      4. South Africa
                                                                                                                      5. Egypt
                                                                                                                      6. Nigeria
                                                                                                                      7. Rest of MEA
                                                                                                                    2. LATAM
                                                                                                                      1. LATAM Parkinson's Disease Drugs Market, By Mechanism of Action
                                                                                                                        1. Dopamine Agonists
                                                                                                                          1. Anticholinergic
                                                                                                                            1. MAO-B inhibitors
                                                                                                                              1. Amantadine
                                                                                                                                1. Carbidopa-levodopa
                                                                                                                                  1. COMT Inhibitors
                                                                                                                                    1. Other Mechanisms of Action 
                                                                                                                                    2. Brazil
                                                                                                                                      1. Brazil Parkinson's Disease Drugs Market, By Mechanism of Action
                                                                                                                                        1. Dopamine Agonists
                                                                                                                                          1. Anticholinergic
                                                                                                                                            1. MAO-B inhibitors
                                                                                                                                              1. Amantadine
                                                                                                                                                1. Carbidopa-levodopa
                                                                                                                                                  1. COMT Inhibitors
                                                                                                                                                    1. Other Mechanisms of Action 
                                                                                                                                                  2. Mexico
                                                                                                                                                  3. Argentina
                                                                                                                                                  4. Chile
                                                                                                                                                  5. Colombia
                                                                                                                                                  6. Rest of LATAM

                                                                                                                                              Related Reports

                                                                                                                                              Global Report
                                                                                                                                              The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global inflight catering market size was valued at USD 12.24 billion in 2022. It is estimated to reach USD 32.13 billion by 2031, growing at a CAGR of 11.32% during the forecast period (2023–2031). The primary catalyst for growth in the inf
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                              Buy Now

                                                                                                                                              Purchase Benefits

                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                              • Completely customizable scope
                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                              • Dedicated account manager
                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                              • Permission to print the report

                                                                                                                                              We are featured on :

                                                                                                                                              www.straitsresearch.com
                                                                                                                                              © Copyright . All rights Reserved.